human amnion derived pluripotent mesenchymal stem cell therapy (KUTLO-NITT)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namehuman amnion derived pluripotent mesenchymal stem cell therapy (KUTLO-NITT)
Drug Alias NameiHAM
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A